Cargando…

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy

PURPOSE: To compare the efficacy of low-fluence photodynamic therapy (PDT) and PDT with half-dose verteporfin in chronic central serous chorioretinopathy (CSC). PATIENTS AND METHODS: The medical records of 64 eyes from 60 patients with chronic CSC were retrospectively reviewed; 36 eyes received low-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkin, Zeynep, Perente, Irfan, Ozkaya, Abdullah, Alp, Dilek, Agca, Alper, Aygit, Ebru Demet, Korkmaz, Selcuk, Yazici, Ahmet Taylan, Demirok, Ahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983077/ https://www.ncbi.nlm.nih.gov/pubmed/24741287 http://dx.doi.org/10.2147/OPTH.S58617

Ejemplares similares

Topical Nepafenac in Treatment of Acute Central Serous Chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2013)

Steroid-induced central serous chorioretinopathy in a patient with non-arteritic anterior ischemic optic neuropathy
por: Alkin, Zeynep, et al.
Publicado: (2015)

The Role of Epiretinal Membrane on Treatment of Neovascular Age-Related Macular Degeneration with Intravitreal Bevacizumab
por: Alkin, Zeynep, et al.
Publicado: (2013)

Is Spectral-Domain Optical Coherence Tomography Essential for Flexible Treatment Regimens with Ranibizumab for Neovascular Age-Related Macular Degeneration?
por: Ozkaya, Abdullah, et al.
Publicado: (2013)

Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients
por: Ozkaya, Abdullah, et al.
Publicado: (2013)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak, Thuss, et al.
Publicado: (2015)

The comparison of multimodal imaging findings of central serous chorioretinopathy patients in regard to the early anatomically treatment response to half-fluence photodynamic therapy: a retrospective case–control study
por: Ozkaya, Abdullah, et al.
Publicado: (2017)

Long Term Result of Intravitreal Bevacizumab in a Patient Newly Transformed to Proliferative Macular Telangiectasia Type 2
por: Ozkaya, Abdullah, et al.
Publicado: (2013)

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim, Shaheen P, et al.
Publicado: (2013)

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
por: Ng, Winnie WK, et al.
Publicado: (2011)

Diurnal Choroidal Thickness Changes in Normal Eyes of Turkish People Measured by Spectral Domain Optical Coherence Tomography
por: Osmanbasoglu, Ozen Ayrancı, et al.
Publicado: (2013)

Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion
por: Ozkaya, Abdullah, et al.
Publicado: (2013)

Refractive lenticule extraction (ReLEx) through a small incision (SMILE) for correction of myopia and myopic astigmatism: current perspectives
por: Ağca, Alper, et al.
Publicado: (2016)

Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Noh, Sung Rae, et al.
Publicado: (2019)

Comparison of three methods of tonometry in normal subjects: Goldmann applanation tonometer, non-contact airpuff tonometer, and Tono-Pen XL
por: Yilmaz, Ihsan, et al.
Publicado: (2014)

Efficacy of Selective Laser Trabeculoplasty in Medically Uncontrolled Glaucoma
por: Sayin, Nihat, et al.
Publicado: (2013)

Selective Laser Trabeculoplasty for Glaucoma Secondary to Emulsified Silicone Oil after Pars Plana Vitrectomy: A Pilot Study
por: Alkin, Zeynep, et al.
Publicado: (2014)

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy
por: Ma, Dae Joong, et al.
Publicado: (2018)

Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
por: Iacono, Pierluigi, et al.
Publicado: (2020)

Long-Term Effect of Half-Fluence Photodynamic Therapy on Fundus Autofluorescence in Acute Central Serous Chorioretinopathy
por: Stattin, Martin, et al.
Publicado: (2020)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2022)

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
por: Chubachi-Kamimura, Aya, et al.
Publicado: (2023)

Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
por: Fujita, Kyoko, et al.
Publicado: (2020)

Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Kumashiro, Shun, et al.
Publicado: (2021)

3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
por: Hu, Yu-Chen, et al.
Publicado: (2021)

Focal Laser Photocoagulation in Non-Center Involved Diabetic Macular Edema
por: Perente, Irfan, et al.
Publicado: (2014)

Comparison of intravitreal ranibizumab between phakic and pseudophakic neovascular age-related macular degeneration patients: Two-year results
por: Ozkaya, Abdullah, et al.
Publicado: (2015)

Anti-Vascular Endothelial Growth Factor Treatment for Proliferative Macular Telangiectasia Type 2
por: Alkin, Zeynep, et al.
Publicado: (2016)

Corneal Backscatter Analysis by In Vivo Confocal Microscopy: Fellow Eye Comparison of Small Incision Lenticule Extraction and Femtosecond Laser-Assisted LASIK
por: Agca, Alper, et al.
Publicado: (2014)

Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
por: Yanık, Özge, et al.
Publicado: (2022)

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis
por: Aisu, Nao, et al.
Publicado: (2022)

Simultaneous Transepithelial Topography-Guided Photorefractive Keratectomy and Accelerated Cross-Linking in Keratoconus: 2-Year Follow-Up
por: Ahmet, Sibel, et al.
Publicado: (2018)

Effect of Fluorometholone/Tetrahydrozoline Fixed Combination on Conjunctival Autograft Morphology after Primary Pterygium Excision
por: Ozgurhan, Engin Bilge, et al.
Publicado: (2013)

Detailed Ophthalmologic Evaluation of Posterior Microphthalmos
por: Alkin, Zeynep, et al.
Publicado: (2014)

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
por: Eris, Erdem, et al.
Publicado: (2017)

Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child
por: Özkaya, Abdullah, et al.
Publicado: (2016)

Visual and Refractive Outcomes of Small-Incision Lenticule Extraction in High Myopia: 5-Year Results
por: Ağca, Alper, et al.
Publicado: (2018)

Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor
por: Eris, Erdem, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rq0qveqd94mmgimb7rovgpk4uj